Compass Therapeutics

Contributing Author

Recent Articles by Compass Therapeutics

Nov-25	Compass Therapeutics to Participate in Upcoming December Investor Events CMPX GlobeNewswire
Nov-05	Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update CMPX GlobeNewswire
Nov-04	Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting CMPX GlobeNewswire
Nov-03	Compass Therapeutics to Participate in Upcoming November Investor Events CMPX GlobeNewswire
Aug-26	Compass Therapeutics to Participate in Upcoming September Investor Events CMPX GlobeNewswire
Aug-12	Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering CMPX GlobeNewswire
Aug-12	Compass Therapeutics Announces Proposed Public Offering CMPX GlobeNewswire
Aug-11	Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update CMPX GlobeNewswire
Aug-08	Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 CMPX GlobeNewswire
May-28	Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference CMPX GlobeNewswire
May-08	Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update CMPX GlobeNewswire
May-06	Compass Therapeutics to Participate in Upcoming May Investor Events CMPX GlobeNewswire